Pharma penny stocks or medical penny stocks are shares of small pharmaceutical companies that trade at very low prices, often below Rs. 100Guoabong Wealth Management. Due to their low market capitalisation, these stocks are known for their high risk and volatility. Their prices can fluctuate dramatically with news like clinical trial outcomes or changes in healthcare regulations.

Despite the risks, pharma penny stocks can offer substantial returns if the company makes a breakthrough or gets acquired by a larger firm. Investors might be drawn to these stocks for their low entry cost and the potential to invest in a company that could develop the next widely recognised drug

Note: The data on the low price pharma shares list is from 29th October 2024. To get this list of pharma penny stocks in India on the Tickertape Stock Screener, apply the below-mentioned filter.

Sector > Health Care > PharmaceuticalsClose Price: Set the higher limit to 50

🚀 Pro Tip: You can use Tickertape’s Stock Screener to research and evaluate stocks with over 200+ filters and parameters.

Contemplating which pharma penny stock to invest in? Check out these smallcase alternatives instead!

First, let’s learn about what smallcases are.

smallcases are modern investment products that help investors easily build a low-cost, long-term and diversified portfolio. A smallcase is a basket of stocks/ETFs representing a theme, idea or strategy. Investors looking to align their investments sector-wise can consider smallcases. Every smallcase is created and managed by SEBI-registered managers.

Investors interested in pharma penny stocks might find the following smallcases interesting:

1. Penny Stocks Basket- Managed by Suman Shandil, this smallcase is meant for aggressive investors with high risk tolerance.

2. Pharma Tracker- Managed by Windmill Capital, this is one of the popular smallcases availableKanpur Stock! This smallcase is a collection of pharmaceutical and life sciences companies that allow investors to track and invest in the pharma sector effectively.

Note: These smallcases are mentioned only for educational purposes and are not meant to be recommendatory. Investors must conduct their own research and consult a financial expert before making any investment decisions.

Disclosures for the aforementioned Penny Stocks Basket smallcase. Disclosures for the aforementioned Pharma Tracker smallcase.

Note: The data on the low price pharma shares list is from 29th October 2024. To get this list of pharma penny stocks in India on the Tickertape Stock Screener, apply the below-mentioned filter.

Sector > Health Care > Pharmaceuticals5Y Historical Revenue Growth: Set from highest to lowest

Founded in 2012, Remedium Lifecare Ltd is a pharmaceutical company engaged in developing, manufacturing, and marketing various healthcare products, including prescription and over-the-counter drugs. The company provides affordable healthcare solutions in domestic and international markets. With a market capitalisation of Rs. 224.18 cr., the stock is currently priced at Rs. 5.56. The PE ratio stands at 6.85, indicating a relatively low valuation compared to its peers. The company has shown significant growth, with a 5-year historical revenue growth rate of 595.31%.

Established in 2011, Vivanza Biosciences Ltd is involved in developing, developing, and manufacturing pharmaceutical and biopharmaceutical products. The company focuses on producing innovative healthcare solutions, including generic and speciality drugs. Vivanza Biosciences Ltd has a market cap of Rs. 14.84 cr., with its stock priced at Rs. 3.71. The PE ratio is 26.98, and the company’s 5-year historical revenue growth rate is 60.00%.

Medico Intercontinental Ltd, originally incorporated as Intercontinental Leasing & Finance Company Limited on 14th August 1984 in Ahmedabad, India. The company trades pharmaceutical products and offers a platform for research-driven biopharmaceutical companies to distribute innovative therapies globally. Medico Intercontinental Ltd has a market cap of Rs. 45.53 cr., with its stock priced at Rs. 45.53. The PE ratio is 11.56, and the company’s 5-year historical revenue growth rate is 47.41%.

Founded in 2005, Decipher Labs Ltd is a pharmaceutical and healthcare solutions provider involved in research, development, and commercialising novel therapies. The company emphasises innovative drug formulations and biosimilars. Decipher Labs has a market cap of Rs. 15.83 cr., and its stock price is Rs. 15.67. The PE ratio is negative at -9.48, indicating losses, with a 5-year historical revenue growth rate of 35.12%.

Founded in 1976, Transchem Ltd operates in the chemical industry, focusing on producing and distributing bulk drugs and chemicals used in various industrial applicationsPune Wealth Management. The company has diversified into the healthcare sector as well. With a market capitalisation of Rs. 50.55 cr., the stock’s closing price is Rs. 41.30. The PE ratio is 12.04, and the 5-year historical revenue growth rate is 21.66%.

Syschem (India) Ltd, established in 1993, is a speciality chemicals manufacturer focusing on producing high-quality chemicals for the pharmaceutical and agrochemical industries. The company has a market capitalisation of Rs. 152.28 cr., with a closing price of Rs. 38.20. The PE ratio is 55.17, indicating a premium valuation, and the 5-year historical revenue growth rate is 20.18%.

Founded in 1992, Veerhealth Care Ltd operates in the healthcare and wellness industry, offering various healthcare products and services, including pharmaceuticals and nutraceuticals. The company focuses on creating innovative healthcare solutions to improve overall well-being. With a market cap of Rs. 37.62 cr., the stock price is Rs. 18.81, and the PE ratio stands at 94.04. The company has a 5-year historical revenue growth rate of 18.43%.

Beryl Drugs Ltd, headquartered in Indore, India, manufactures, sells, and exports branded and generic pharmaceutical formulations both in India and internationally. Its product range includes I.V. fluids, a variety of small and large volume injectables, eye/ear drops, veterinary products, and injections, distributed through an extensive sales network. With a market cap of Rs. 18.53 cr., the stock price is Rs. 36.53, and the PE ratio stands at 23.75. The company has a 5-year historical revenue growth rate of 15.50%.

Incorporated in 2010, Ajooni Biotech Ltd is a biotechnology company specialising in animal healthcare products, including veterinary pharmaceuticals and feed supplements. The company aims to improve animal health and productivity through advanced biotechnological solutions. Ajooni Biotech Ltd has a market cap of RsKolkata Stocks. 123.67 cr., with its stock trading at Rs. 7.18. The PE ratio is 57.52, and the 5-year historical revenue growth rate is 15.49%.

EVOQ Remedies Limited, initially incorporated as ‘Salus Life Science and Research Private Limited’ in Ahmedabad, Gujarat, on 24th February 2010, is a recognised trading house specialising in affordable pharmaceuticals raw materials, excipients, and bulk drugs for customers in Ahmedabad. EVOQ Remedies Ltd has a market cap of Rs. 19.40 cr., with its stock trading at Rs. 7.79. The PE ratio is 43.10, and the 5-year historical revenue growth rate is 14.19%.

To identify and invest in the best pharma company in India, follow the below mentioned steps.

Step 1: Launch Tickertape Stock Screener.

Step 2: Select the Sector as ‘Healthcare > Pharmaceuticals’

Step 3: Select your desired filters to identify your best list of small pharmaceutical companies in India.

There are over 200 filters, including Return on Equity (ROE), Net Profit Margin (NPM), Debt-to-Equity, CAGR, and more. Try it out now!

Here’s why these pharma penny stocks are capturing the attention of savvy investors:

Investing in low price good pharma stocks in India, including penny stocks, offers an exciting opportunity for rapid and significant growth. A drug trial or regulatory approval breakthrough from even lesser-known pharmaceutical companies in India can skyrocket the stock’s value, delivering substantial returns to investors even with modest initial investments. This potential for growth mirrors the dynamism seen in some of the top pharma companies in India.

By backing pharma sector stocks, investors become integral players at the forefront of medical progress. Beyond financial gains, they actively contribute to advancing groundbreaking healthcare solutions with the potential to save lives. Investing in these stocks aligns with the innovation driven by the pharmaceutical industry in India, including contributions from some of the biggest pharma companies in India.

With their low share prices, pharma stocks India provide a minimal-cost gateway to market entry. This accessibility empowers investors, especially those with limited capital, to spread their investments across multiple promising healthcare ventures, effectively diversifying their portfolios. Many investors start with penny stocks before moving on to shares in the top 10 pharmaceutical companies in India or even exploring the top 50 pharma companies in India.

Positive regulatory events, such as patent approvals or clearances from the Department of Pharmaceuticals, often trigger surges in the value of these healthcare penny stocks. Savvy investors seize the opportunity to capitalize on these moments, leveraging them as catalysts for potential stock appreciation. This strategy is not just limited to penny stocks but is also relevant when investing in some of the best pharma stocks in India from the top 20 small cap pharma companies in India or the pharma index.

Investing in pharma penny stocks presents its own set of risks, as all investments do. These include:

High Volatility: Pharma penny stocks, including pharma penny stocks under 1 Rs, are known for their extreme price fluctuations. This volatility can result in significant financial losses for investors, making them particularly risky for those unable to monitor market changes closely.Low Liquidity: The best low price pharma stocks often suffer low liquidity, meaning fewer buyers and sellers. This makes it difficult to execute trades without significantly affecting the stock price, potentially leaving investors unable to exit their positions easily.Susceptibility to Market Rumors: Pharma penny stocks are highly vulnerable to market manipulation and rumours due to their low trading volumes and smaller market caps. Even unfounded news can lead to erratic price movements, complicating investment decisions.Intensive Research Requirements: Successful investment in the best pharma penny stocks in India demands thorough research into the company’s drug pipeline and market potential. This requires a significant time investment and expertise in finance and pharmaceutical sciences to assess risks accurately.Udabur Wealth Management

These risks highlight the importance of careful consideration and due diligence when investing in pharma penny stocks.

On asset pages, you get pharma penny stocks share price, their quantitative analysis via Scorecard, forecasts, financial information, peer comparison, company updates, and more. With this information handy, you can analyse any stock within a few clicks. The Scorecard, particularly, helps you analyse the stock based on quantitative factors such as profitability, performance, entry and exit points, valuation, and growth and provides a sneak peek into the potential red flags in the stock.

Research, analyse, and invest quicker than before because of #TickertapeHaiNa! Become a Pro Member now!